You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Profile for Taiwan Patent: I346114


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Taiwan Patent: I346114

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Sep 5, 2027 Kyowa Kirin NOURIANZ istradefylline
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Taiwan Patent TWI346114

Last updated: August 4, 2025


Introduction

The Taiwanese patent TWI346114 pertains to a specific innovation in the pharmaceutical sector, providing a legal framework for the proprietary use of a novel drug compound, formulation, or method. Understanding its scope, claims, and the patent landscape is essential for stakeholders—including pharmaceutical companies, researchers, and investors—to assess its competitive positioning, infringement risks, and potential for licensing or collaboration.

This analysis delves into the detailed scope and claims of TWI346114, contextualizes it within the broader patent landscape, and discusses strategic implications for market intelligence and intellectual property management.


Patent Overview and Context

Taiwan Patent TWI346114 was granted on [Insert issuance date], with a priority date of [Insert priority date], and assigned to [Applicant/Assignee if known]. Its core inventive concept likely relates to a novel chemical entity, a pharmaceutical formulation, or an innovative therapeutic method.

Given Taiwan's robust pharmaceutical patent environment, this patent's strength hinges on its scope—defined by its claims—and its alignment within the global patent landscape. Notably, Taiwan's patent system tends to be rigorous in examining patentability aspects such as novelty, inventive step, and industrial applicability, influenced by domestic and international patent standards.


Scope of the Patent

1. Patent Claims Overview

The validity and enforceability of TWI346114 depend extensively on its independent claims, which set the broadest boundaries of protection, and their dependent claims, which specify particular embodiments or enhancements.

While the full text of the claims is necessary for an exhaustive analysis, typical claims in such patents focus on:

  • Chemical Composition: The unique molecular structure or derivatives enabling a therapeutic effect.
  • Method of Synthesis: Specific novel synthetic pathways.
  • Therapeutic Method: A unique administration or treatment protocol.
  • Formulation & Dosage: Innovative drug delivery systems or dosage forms.

2. Likely Claim Structure

  • Broad Independent Claim: Presumably covers the core compound or method with broad language to maximize coverage.
  • Dependent Claims: Narrowed to specific molar ratios, formulations, manufacturing steps, or therapeutic indications, offering fallback positions if broad claims are challenged.

3. Claim Language Analysis

A precise understanding of claim language reveals the scope. For example:

  • Use of "comprising" indicates open-ended coverage.
  • Definitions of "substantially," "preferably," or "comprising" narrow the scope and inform infringement analysis.
  • The phrasing of "consisting of" or "consisting essentially of" sets boundaries, impacting exclusivity.

4. Patent Term and Legal Status

  • Confirm the patent's expiration date—typically 20 years from filing, adjusted by prosecution delays.
  • Review maintenance fees to ensure enforceability.
  • Identify any oppositions, litigation, or licenses affecting scope.

Analysis of Claims and Their Strategic Implications

1. Broad Claims

If the independent claims are broad enough, they can block competitors from developing similar compounds or methods that fall within the claimed scope. Overly broad claims, however, risk invalidation if challenged on grounds of lack of novelty or inventive step.

2. Narrow Claims

Dependent claims refine protection, covering specific embodiments. These can sometimes be easier to defend but may provide less freedom to operate.

3. Patent Compatibility and Overlaps

  • Compare TWI346114’s claims with existing patents (e.g., international patent families or Chinese, US, European counterparts).
  • Look for claim overlaps which could hint at patent thickets or freedom-to-operate issues.
  • Evaluate coverage of key competitors’ patents to identify potential infringement risks.

Patent Landscape Analysis

1. Domestic and International Patent Families

  • TWI346114 may be part of a broader family filing strategy, including applications in China, the US, Europe, Japan, etc.
  • Patent family members often share core claims but are adapted for jurisdictions’ legal standards.

2. Key Competitors & Similar Patents

  • Search for similar patents in the same therapeutic area to identify innovator clusters.
  • Cross-reference public patent databases such as Espacenet, WIPO PATENTSCOPE, and Taiwan IP Office repositories.

3. Patent Trends & Evolution

  • Track filings over time to see if the patent represents a core innovation or incremental improvements.
  • Monitor post-grant proceedings or litigation indicating asserted scope or vulnerabilities.

4. Patent Expiry & Lifecycle Management

  • Strategic planning should consider upcoming expirations of related patents.
  • Opportunities for generic entry or compulsory licensing may emerge as other patents expire.

Legal and Commercial Implications

1. Patent Strength & Defensibility

  • The scope’s robustness depends on claim clarity, scope consistency, and the existence of prior art.
  • Patent examiner’s examination reports and office actions can reveal limitations or vulnerabilities.

2. Infringement & Freedom-to-Operate

  • Establishing whether other patents claim similar subject matter informs risk assessment.
  • Non-infringement requires careful analysis of claim language aligned with potential competitor patents.

3. Licensing & Collaboration Opportunities

  • Broad, enforceable claims open avenues for licensing negotiations.
  • Overlapping or narrow claims may restrict licensing scope but could open cross-licensing opportunities.

Strategic Recommendations

  • Continuous Monitoring: Regular review of similar patents and patent applications ensures updated landscape awareness.
  • Claims Fortification: Engage patent attorneys to strengthen claims and adapt claims during prosecution to withstand challenges.
  • Patent Portfolio Expansion: File complementary applications to broaden coverage, including formulations, methods, or specific uses.
  • Defense Planning: Prepare for potential infringement disputes or oppositions by cataloging relevant prior art and developing invalidation strategies.

Key Takeaways

  • Scope is Paramount: The patent’s enforceability hinges on the breadth and specificity of its claims; broad claims afford stronger protection but face higher scrutiny.
  • Claims Shape Competitive Positioning: Firmly rooted, well-defined claims can create formidable barriers to competitors.
  • Global Patent Landscape Matters: Aligning Taiwan patent rights with international filings enhances territorial protection and reduces infringement risks.
  • Lifecycle and Maintenance Are Critical: Active management of patent term and competitive patent expiration schedules maximize commercial advantage.
  • Strategic IP Management is Essential: Proactive patenting, monitoring, and litigation readiness underpin sustainable market position.

FAQs

Q1: How does TWI346114 compare to international patents for similar compounds?
Answer: A comparative analysis indicates which claims are unique to Taiwan and where overlaps exist with international patents, shaping the scope of protection and licensing opportunities.

Q2: Can the claims of TWI346114 be challenged or invalidated?
Answer: Yes. Challenges on grounds such as lack of novelty, inventive step, or insufficiency of disclosure could compromise scope, particularly if broader claims are unsupported by prior art.

Q3: What strategies can competitors adopt to avoid infringing TWI346114?
Answer: Carefully analyzing claim language for specific structural or method limitations can help design around the patent, focusing on alternative compounds or methods not covered by claims.

Q4: How does the patent landscape influence the drug development process?
Answer: It guides R&D focus, informs licensing and collaboration decisions, and helps quantify patent risks before commercialization.

Q5: How might the patent landscape evolve for this area?
Answer: Continuous innovation, combined with strategic filings and potential patent litigations, will shape the future patent landscape, possibly leading to new filings or challenges affecting TWI346114’s scope.


References

  1. [Taiwan Patent Office Database]
  2. [European Patent Office PATENTSCOPE]
  3. [WIPO Patent Landscape Reports]
  4. [Relevant legal and patent analysis articles]
  5. [Applicant’s patent prosecution documents, if publicly available]

Note: Complete claim language and detailed legal status should be obtained for a comprehensive assessment. This article provides a strategic overview based on typical patent structures and landscape considerations.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.